Clinical Trial Update: Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of sorafenib and docetaxel in metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Taxotere (docetaxel)

Snippet

Sponsor: Italian Trial in Medical Oncology | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED